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The development of the mammalian cerebral cortex involves a series of mechanisms:
from patterning, progenitor cell proliferation and differentiation, to neuronal migration.
Many factors influence the development of the cerebral cortex to its normal size and
neuronal composition. Of these, the mechanisms that influence the proliferation and
differentiation of neural progenitor cells are of particular interest, as they may have the
greatest consequence on brain size, not only during development but also in evolution.
In this context, causative genes of human autosomal recessive primary microcephaly,
such as ASPM and MCPH1, are attractive candidates, as many of them show positive
selection during primate evolution. MCPH1 causes microcephaly in mice and humans
and is involved in a diverse array of molecular functions beyond brain development,
including DNA repair and chromosome condensation. Positive selection of MCPH1 in the
primate lineage has led to much insight and discussion of its role in brain size evolution.
In this review, we will present an overview of MCPH1 from these multiple angles, and
whilst its specific role in brain size regulation during development and evolution remain
elusive, the pieces of the puzzle will be discussed with the aim of putting together the
full picture of this fascinating gene.
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Introduction: MCPH1 in Brain Development and Evolution
The study of mammalian neurogenesis and cortical development stands at a fascinating intersection
between neuroscience, cell biology, developmental biology, genetics, and evolutionary biology
(Molnár et al., 2014; Paridaen and Huttner, 2014; Sun and Hevner, 2014). The studies of the genes
that cause autosomal recessive primary microcephaly (MCPH) are exemplary of this exciting
synthesis of research fields (Woods et al., 2005; Kaindl et al., 2010; Gilmore and Walsh, 2013).
One of the causative genes of this condition, MCPH1 (syn. BRIT1, Microcephalin), plays a role in
brain development (Jackson et al., 1998, 2002), DNA damage repair (Xu et al., 2004; Lin et al.,
2005; Peng et al., 2009), chromosome condensation (Neitzel et al., 2002; Trimborn et al., 2004;
Yamashita et al., 2011), cancer (Chaplet et al., 2006; Rai et al., 2006; Richardson et al., 2011),
germline function (Liang et al., 2010), and has also provided insights into brain evolution (Evans
et al., 2004, 2005; Wang and Su, 2004; Ponting and Jackson, 2005). Many unanswered questions
remain on this multifaceted gene, such as how the lack of MCPH1 leads to microcephaly, its
molecular mechanisms in neurogenesis, and the key question of its role in the evolution of
brain size.
The development of the cerebral cortex begins with formation and patterning of the
neural tube (Lumsden and Krumlauf, 1996; Rubenstein et al., 1998; Copp et al., 2003),
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which is followed by the amplification of neuroepithelial cells,
the primary neural progenitor cells, and their subsequent
differentiation into downstream progenitors and neurons, or
‘‘neurogenesis’’ (Götz and Huttner, 2005; Paridaen and Huttner,
2014; Sun and Hevner, 2014). A constellation of processes follows
to form a fully developed cerebral cortex, including neuronal
migration (Sidman and Rakic, 1973; Nadarajah and Parnavelas,
2002; Marín and Rubenstein, 2003), axon guidance (Tessier-
Lavigne and Goodman, 1996; Dickson, 2002) and synaptogenesis
(Garner et al., 2002; Waites et al., 2005). In the context of
brain development and evolution, the embryonic development
of the mammalian cerebral cortex (neocortex) is the subject of
prime interest, being the seat of higher brain functions, and has
powerful implications for primate and human evolution (Rakic,
2009; Clowry et al., 2010).
Investigations into cortical malformations give profound
insight into not only developmental and molecular mechanisms,
but also provide a platform to investigate the evolution
of brain size and function (Walsh, 1999; Mochida and
Walsh, 2001; Sun and Hevner, 2014). Amongst these
conditions, congenital microcephaly of genetic etiology
is of particular interest, as they allow the dissection of
fundamental molecular and developmental mechanisms.
Interestingly, these mechanisms may be affected in congenital
microcephaly linked to environmental intrauterine insults,
such as viral infections (Cheeran et al., 2009), alcohol, or
other extrinsic cues, exemplified by the finding that Mcph1,
the mouse ortholog of human MCPH1, was shown to be
down-regulated in a mouse model of microcephaly induced
by early embryonic exposure to a VIP (vasoactive intestinal
peptide) antagonist (Passemard et al., 2011). MCPH1 may be
a common denominator in the pathway causing microcephaly,
encompassing the spectrum of both environmental and genetic
forms of microcephaly. Therefore, given its implication in
diverse molecular and cellular mechanisms during brain
development, investigating MCPH1 function is of particular
interest. Here, an overview of the key issues relating to the
function of MCPH1 in brain development and evolution will be
reviewed.
Autosomal Recessive Primary
Microcephaly (MCPH)
Microcephaly is the clinical finding of a small brain, typically
measured by head circumference (HC), compared to the
population mean values of the age, sex, and ethnicity of
the individual (Woods, 2004; Kaindl et al., 2010; Woods
and Parker, 2013). HC, or more specifically occipito-frontal
circumference (OFC) is commonly used as a surrogate measure
of brain size (Woods et al., 2005); head size being a readily
measurable approximation of brain size, and thus the terms
microcephaly (small head) and microencephaly (small brain) are
generally interchangeable (Gilmore and Walsh, 2013). An OFC
of three standard deviations below the age- and sex-matched
means (<--3 SD) is commonly accepted as a clinical definition
of microcephaly (Woods and Parker, 2013). Furthermore,
microcephaly is subdivided into primary and secondary
microcephaly (Qazi and Reed, 1973). Primary microcephaly
(microcephaly vera) is generally defined as being present at
birth, with no obvious abnormalities other than gross brain
size (Mochida and Walsh, 2001), and has a variety of genetic
and non-genetic causes such as infections (Woods and Parker,
2013), prenatal radiation exposure (Plummer, 1952; Wood
et al., 1967), and prenatal alcohol exposure (Ouellette et al.,
1977; Spohr et al., 1993). Secondary microcephaly is generally
defined as manifesting after birth (Woods and Parker, 2013).
From the perspective of investigating brain development, the
distinction between primary and secondary microcephaly is key,
as primary microcephaly is likely to be related to neurogenesis,
and secondary microcephaly may involve any of the downstream
processes post-neurogenesis (Woods, 2004; Woods et al., 2005).
Furthermore, microcephaly of genetic etiology, or autosomal
recessive primary microcephaly, allows the detailed dissection
of the relevant molecular mechanisms. The pathological defect
in primary microcephaly is likely to fall temporally within the
neurogenic interval and spatially within the neural progenitor
cell compartment, making it ideal for the investigation of the
regulation of brain size. However, in this context it is important
to note that neuronal death due to alterations in diverse
aspects of neuronal differentiation (including but not limited
to neuronal migration and maturation) cannot be excluded,
and may also account for the decrease in brain size seen in
primary microcephaly. The main challenge in this regard is
to determine how the alteration of these different processes at
multiple stages of cortical development, ultimately impacts the
final brain size.
Autosomal recessive primary microcephaly (MCPH) is a
genetically heterogeneous condition (Mochida and Walsh, 2001),
with 12 or more causative genes identified, all of which
produce a clinically indistinguishable phenotype. The loci are
numbered MCPH1 to MCPH12 (Kaindl, 2014), and the genes
identified in this order are: MCPH1 (Jackson et al., 1998,
2002), WDR62 (Roberts et al., 1999; Nicholas et al., 2010),
CDK5RAP2 (Moynihan et al., 2000; Bond et al., 2005), CASC5
(Jamieson et al., 1999; Genin et al., 2012), ASPM (Jamieson
et al., 2000; Pattison et al., 2000; Bond et al., 2002), CENPJ
(Leal et al., 2003; Bond et al., 2005), STIL (Kumar et al.,
2009), CEP135 (Hussain et al., 2012), CEP152 (Guernsey
et al., 2010), ZNF335 (Yang et al., 2012), PHC1 (Awad et al.,
2013), and CDK6 (Hussain et al., 2013). Mutations in CEP63
have also been identified as causing primary microcephaly
(Sir et al., 2011). ASPM (MCPH5) is reported as being the
most common locus for MCPH, with WDR62 (MCPH2)
being the second, followed by MCPH1 and the other loci
being rarer causes of MCPH (Roberts et al., 2002; Darvish
et al., 2010; Nicholas et al., 2010; Sajid Hussain et al.,
2013).
It has long been noted that the MCPH genes are all
related to the mitotic spindle or centrosome (Bond and
Woods, 2006; Bettencourt-Dias et al., 2011), and most MCPH
proteins are located at the centrosome or spindle. However
the more recently identified genes do not appear to be related
to these functions, such as PHC1 which plays a role in
chromatin remodeling and DNA repair (Awad et al., 2013). It
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is interesting to note that MCPH1 traverses multiple functions
related to: transcription activation (Yang et al., 2008), mitotic
spindle and centrosome (Gruber et al., 2011), and DNA
damage repair (Zhou et al., 2013), which raises a possible
link between DNA repair and microcephaly. Although the
hitherto known functions of the MCPH genes are linked to
the cell cycle, the fact that the loss-of-function mutation of
only one gene is sufficient to cause microcephaly excludes
the possibility of functional redundancy. Nevertheless, such
exclusion does not rule out genetic interactions between
MCPH genes. Further investigations of the spatio-temporal
expression patterns of these genes during cortical development
and a detailed assessment of the neurodevelopmental defects
occurring in MCPH patients and mouse model mutants will be
necessary to answer the question of a crosstalk between MCPH
genes, and the identity of a common centrosome- or spindle-
related mechanism regulating brain size (Bond and Woods,
2006).
Genetics of MCPH1
MCPH1 was the first locus identified for MCPH, initially mapped
to 8p22-pter (Jackson et al., 1998). The gene was later identified
and the protein was named Microcephalin (Jackson et al., 2002).
A feature unique to primary microcephaly caused by mutations
in MCPH1 are defects in chromosome condensation, specifically
premature chromosome condensation (PCC) in early G2-phase,
and delayed decondensation post-mitosis (Trimborn et al., 2006).
This condition was originally named PCC syndrome (Neitzel
et al., 2002); however mutations in MCPH1 were later identified,
and PCC and primary microcephaly caused by mutations in
MCPH1 were found to be allelic disorders (Trimborn et al.,
2004). PCC is detected in cytogenetic preparations, as a high
proportion of prophase-like cells and poor quality metaphase
G-banding (Trimborn et al., 2004). PCC is a pathognomonic
feature of MCPH1, being absent in all other mutations of MCPH
genes. Another autosomal recessive condition characterized by
microcephaly with additional craniofacial features and mitotic
and chromosomal defects (Tommerup et al., 1993), was later
found to also be caused by mutations in MCPH1 (Farooq
et al., 2010). MCPH1 was also identified independently in
a screen for transcriptional repressors of hTERT (catalytic
subunit of human telomerase) and named BRIT1, BRCT-repeat
inhibitor of hTERT expression (Lin and Elledge, 2003), which
was later shown to be the same gene as MCPH1 (Lin et al.,
2005). Taken together, these molecular features of MCPH1
collectively reveal that the gene is implicated in diverse processes
that are crucial not only for proper brain development, but
also for the maintenance of genome integrity (Liang et al.,
2010).
MCPH1 Protein Structure and Function
In human and mouse (Mus musculus), the MCPH1 coding
sequence contains 14 exons, distributed across 200 kb of genomic
DNA. The protein contains three BRCT (BRCA1 C-Terminal)
domains (Figures 1, 2), which were first described in BRCA
proteins and mediate protein-protein interactions (Koonin et al.,
1996; Huyton et al., 2000). One domain is located at the
N-terminal side of the MCPH1 protein (BRCT1), and a tandem
of two domains spans the C-terminal sequence (BRCT2/3). These
domains are predicted to be crucial for function (Jeffers et al.,
2008) and may be differentially involved in the diverse roles of
MCPH1 by mediating interactions with distinct partners. In line
with this notion, repeats of BRCT domains, such as BRCT2/3,
have been shown to preferentially interact with phosphorylated
residues (Woods et al., 2012).
A number of studies have reported on MCPH1 interaction
partners and differential functions of the N-terminal BRCT1
domain, and the more C-terminal BRCT2/3 domains (Figure 1).
Two regions of human MCPH1: an N-terminal fragment
containing BRCT1 (residues 1--195), and a central fragment
(residues 381--435) interact with different subunits of condensin
II to regulate chromosome condensation (Yamashita et al., 2011).
The N-terminal sequence (residues 1--48) was shown to be
necessary to recruit BAF170, a component of the chromatin
remodeling complex SWI/SNF, to relax chromatin for DNA
repair (Peng et al., 2009). This suggests a possible role of MCPH1
in chromatin conformation. BRCT2/3 domains have been shown
to bind to E2F1 to form a complex able to transactivate BRCA1
and CHK1 (Yang et al., 2008). Interactions between MCPH1
BRCT2/3 domains and Cdc27, a subunit of the anaphase-
promoting complex (Singh et al., 2012b), and a phosphorylated
domain of H2A.X have also been reported (Singh et al.,
2012a). On the other hand, a truncated MCPH1 protein lacking
BRCT2/3, is able to complement the defective chromosome
condensation in human MCPH1-deficient cells (Gavvovidis
et al., 2012), indicating that these domains are dispensable for this
function. Molecular interactions between MCPH1 and partners
may likely be regulated by post-translational modifications.
In line with this notion, Ser322 phosphorylation of MCPH1
by ATR is required for TopBP1 recruitment and sustained
ATR signaling for DNA repair (Zhang et al., 2014). Further
mechanistic dissection of the functions of BRCT1 and BRCT2/3
domains will allow a better definition of the different molecular
and biochemical mechanisms impaired by MCPH1 mutations.
Human MCPH1 Mutations
A large number of homozygous mutations in MCPH1
causing primary microcephaly have been identified (Table 1;
Figures 1, 2). These include large deletions of exons (Garshasbi
et al., 2006; Darvish et al., 2010; Pfau et al., 2013), single base-
pair insertions and deletions (Trimborn et al., 2004; Darvish
et al., 2010; Sajid Hussain et al., 2013), nonsense mutations
(Jackson et al., 2002; Farooq et al., 2010; Hosseini et al., 2012),
missense mutations (Trimborn et al., 2005; Darvish et al., 2010;
Leung et al., 2011; Ghani-Kakhki et al., 2012), and one splice
site mutation (Darvish et al., 2010). Interestingly, all missense
mutations identified so far are located in exons 2 or 3 (Table 1;
Figure 1), which is within the N-terminal BRCT domain
(BRCT1; see previous section on MCPH1 protein). The missense
mutations all lead to non-conservative changes in an amino
acid residue: threonine to arginine (c.80C>G, p.Thr27Arg)
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which is polar uncharged to positively charged (Trimborn
et al., 2005), histidine to glutamine (c.147C>G, p.His49Gln)
which is positively charged to polar uncharged (Darvish et al.,
2010), serine to leucine (c.215C>T, p.Ser72Leu) which is
polar uncharged to non-polar (Darvish et al., 2010; Ghani-
Kakhki et al., 2012), and tryptophan to arginine (c.223T>C,
p.Trp75Arg) which is non-polar aromatic to positively charged
(Ghani-Kakhki et al., 2012). These mutated residues are highly
conserved during evolution, Thr27 being conserved in orthologs
of MCPH1 in mammals and amphibians (Trimborn et al., 2005).
Ser72 and Trp75 are conserved in all vertebrates and Drosophila,
and these two residues are also conserved in BRCT domains of
BRCA1 (Ghani-Kakhki et al., 2012). In one case a homozygous
double mutation in consecutive codons (c.149T>G, c.151A>G;
p.Val50Gly, p.Ile51Val) was found, which leads to conservative
residue changes (both non-polar to non-polar); however
still within the N-terminal BRCT domain. Molecular and
biochemical studies of full-length MCPH1 proteins harboring
these various amino acid changes may be a powerful tool in
correlating MCPH1 genotype and molecular function with
phenotype.
As previously noted for ASPM (Nicholas et al., 2009),
correlations between mutation and phenotype, such as the
severity of microcephaly, could not be established so far
FIGURE 1 | Schematic of MCPH1 gene and protein domain structures
and the positions of reported mutations in humans and mice.
(A) Schematic of MCPH1 gene intron-exon structure (upper) and protein
domain structures (lower), which are highly conserved between mouse and
human. The MCPH1 coding sequence includes 14 exons shown as black
rectangles numbered from 1--14. The three BRCT domains are shaded in
green. Factors interacting with the BRCT domains are indicated below each
domain. A domain including residues 381--435 in exon 8 and interacting with
condensin II is shaded gray, and the phosphorylation site Ser322 (S322P)
important for TopBP1 recruitment is also shown. (B) Reported mutations in
MCPH1 causing primary microcephaly are indicated on the gene schematic
(see Table 1; Figure 2 for amino acid changes). The extent of the deletions is
indicated as colored bars below the gene structure. (C) Schematic of the four
reported Mcph1 mutations in mice (see also Table 2). For targeted deletions,
the triangles overlaid on the intron flanks the exons that were targeted for
deletion, with the allele name indicated by the same color below. For the gene
trap mutation and knockout-first allele, the site of the insertion is indicated by a
triangle above the intron, with the corresponding allele name in the same color.
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FIGURE 2 | ClustalX alignment of human MCPH1 and mouse Mcph1
proteins. Conserved amino acids are shown in bold characters. Blue upper
lines indicate BRCT domains, and red underlines indicate nuclear localization
signals (Gavvovidis et al., 2012). Amino acid residues mutated in microcephaly
(either nonsense or missense; see Table 1; Figure 1) are in red.
(Table 1). One notable exception is the p.Thr27Arg missense
mutation, which shows only a mild microcephaly (--2.4 SD
at birth), and the fraction of prophase-like cells being only
marginally higher than controls (Trimborn et al., 2005; Ghani-
Kakhki et al., 2012). Meta-analysis of genotype and phenotype
correlations are hampered however by the rarity of patients with
MCPH1 mutations, and by the fact that the HC data is reported at
birth in some cases (Trimborn et al., 2005) but often at older ages
for others, and often only a range of HCs are shown for multiple
individuals within a family (Darvish et al., 2010). Similarly, PCC
is often reported qualitatively (Pfau et al., 2013), without a careful
quantification of prophase-like cells as seen in other studies
(Ghani-Kakhki et al., 2012). Molecular studies comparing the
activities of the mutant proteins may aid in answering some of
these questions (Leung et al., 2011), and will provide powerful
clues in understanding the mechanisms of MCPH1.
Mouse Models of Mcph1 Deficiency:
Microcephaly Phenotype
A number of mouse models for Mcph1 loss-of-function have
been reported (Table 2; Figure 1). These mutant mouse
lines have been successful in recapitulating the features of
primary microcephaly and PCC caused by mutations in MCPH1
in humans. The first study demonstrating a microcephaly
phenotype in a Mcph1 null mutant mouse model (Gruber et al.,
2011) was generated by targeted deletion of Mcph1 exon 4--5
(Mcph1tm1.1Zqw). A follow-up study of this mouse model was
reported by the same group (Zhou et al., 2013). In homozygous
Mcph1tm1.1Zqw mutant mice, the size of the newborn mouse
brain was visibly smaller, and brain weight was also reduced,
fulfilling the criteria of human primary microcephaly at a
gross anatomical level. Histological examination of the newborn
brains revealed an approximate 20% reduction in both the
radial thickness and the lateral extent of the neocortex. The
Mcph1 mutant brain at embryonic day (E) 13.5 was reported
as reduced, and the cortical wall was thinner at E15.5 (Gruber
et al., 2011), implying an early defect. Interestingly, in adult
mutant mice, the anterior portion of the brain (defined in this
case as the olfactory bulb, cerebrum, and thalamus) showed a
more significant reduction compared to the remaining posterior
portion. Moreover, histological examination of the cerebellum
at post-natal day (P) 21 was reportedly normal suggesting
that MCPH1 may not be required for the development of the
cerebellar cortex (Zhou et al., 2013).
Importantly, MCPH1 mutant mice were also reported to have
an approximate 20% reduction in body weight (at P0, P21, and
P180; i.e., at birth, weaning, and adult) and the proportion of
brain weight to body weight showed no significant difference
compared to controls (Zhou et al., 2013). Short stature is a
variable feature of human MCPH1 and is seen in some patients
(Trimborn et al., 2004). However, a proportionate reduction in
both brain and body weight, raises questions of the specificity
of Mcph1 as a sole brain size regulator, at least in the mouse
model. In another mouse model, a Mcph1 null mutant generated
by a targeted deletion of exon 2 (Mcph1tm1.2Kali), growth
retardation was also found, also showing an approximate 20%
reduction in weight; however brain weights were not reported
in this study (Liang et al., 2010). The answer to the question
of a specific effect of Mcph1 on brain size, rather than an
effect on overall body size, will require the analysis of mouse
conditional mutants, with specific inactivation in the brain or
in the neocortex. In contrast, reported mouse models of ASPM
show a specific reduction in brain weight, with no or minimal
reduction in body weight (Pulvers et al., 2010; Fujimori et al.,
2014).
Two other mouse models of Mcph1 have been reported,
one generated from gene trap ES cells (Skarnes et al., 2004),
and another harboring a knockout-first allele (Skarnes et al.,
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TABLE 1 | Reported mutations in MCPH1 causing autosomal recessive primary microcephaly.
Mutation Protein Exon HC Reference
del exon 1--6 ? 1--6 --3 SD Garshasbi et al. (2006),
Darvish et al. (2010)
del exon 1--11 ? 1--11 --3 SD (birth)
<--5 SD (10 m)
Pfau et al. (2013)
c.74C>G p.Ser25Ter 2 --5 to --10 SD Jackson et al. (2002)
c.80C>G p.Thr27Arg 2 --2.4 SD (birth)
--3 SD (6 yr)
Trimborn et al. (2005)
del exon 2--3 ? 2--3 --6 to --8 SD Darvish et al. (2010)
del exon 3 ? 3 --6 to --10 SD Darvish et al. (2010)
c.136C>T p.Gln46Ter 3 <--4 SD Hosseini et al. (2012)
c.147C>G p.His49Gln 3 --7 to --9 SD Darvish et al. (2010)
c.149T>G; c.151A>G p.Val50Gly; p.Ile51Val 3 <0.4th centile Leung et al. (2011)
c.215C>T p.Ser72Leu 3 --6 to --7 SD
--3.5 SD (birth)
Darvish et al. (2010),
Ghani-Kakhki et al. (2012)
c.223T>C p.Trp75Arg 3 --5.7 SD (birth) Ghani-Kakhki et al. (2012)
del exon 4 ? 4 --10 to --11 SD Darvish et al. (2010)
c.302C>G p.Ser101Ter 4 ? Farooq et al. (2010)
c.427_428insA p.Thr143Asnfs 5 --8 to --10 SD Trimborn et al. (2004)
c.436 + 1G>T Splice mut. Intr. 5 --9 SD Darvish et al. (2010)
c.566_567insA p.Asn189fs 6 --6 SD Darvish et al. (2010)
c.1179delG p.Arg393Serfs 8 --8 to --10 SD Sajid Hussain et al. (2013)
The genotype, predicted effect on protein (“?” if unknown or not described), the exon containing the mutation, standard deviation (SD) of the head circumference (HC),
and the reference are shown. All mutations are homozygous.
TABLE 2 | Summary of mouse models of human MCPH1.
Genotype/gene product
Phenotype Reference
Mcph1Gt(RRO608)Byg
Hypomorphic mutation
Gene trap between exons 12--13
Predicted to lack C-term 97aa
Residual wt transcript detected
Body weight normal
Brain/body weight normal
Brain volume normal (MRI)
Defective chromosome condensation
Shortened lifespan; fertility normal
Trimborn et al. (2010)
Mcph1tm1.2Kali
Targeted deletion of exon 2
Null mutation
Growth retardation
IR hypersensitivity
Smaller testis and ovary; infertile
Spermatogenesis defects
No ovarian follicles
Hom born at lower than Mendelian ratio
Liang et al. (2010)
Mcph1tm1.1Zqw
Targeted deletion of exon 4--5
Null mutation
Brain weight reduced (∼20%)
Growth retardation (∼20%)
Brain/body weight normal
Reduction of neocortex in radial and
lateral dimensions; cerebellum normal
Neural progenitor apoptosis and
increased cell cycle exit; deviation of
progenitor mitotic cleavage plane
Smaller testis and ovary; infertile
Gruber et al. (2011),
Zhou et al. (2013)
Mcph1tm1a(EUCOMM)Wtsi
Hypomorphic mutation
Knockout-first allele
Insertion between exons 3--4
Residual wt transcript detected
Brain weight reduced (∼15%)
Growth normal
Hom born at lower than Mendelian ratio
Infertile
Hearing impairment
Chen et al. (2013)
Genotypes of mouse Mcph1 mutations, the phenotypes of the mice, and the references are shown. Allele names obtained from Mouse Genome Informatics
(MGI:2443308). MRI, magnetic resonance imaging; IR, ionizing radiation; Hom, homozygous mutant; wt, wildtype.
2011). The model containing a gene trap vector between
exons 12--13 (Mcph1Gt(RRO608)Byg), which leads to a protein
lacking only the most C-terminal BRCT3 domain, showed
normal body and brain weight, however did exhibit the
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PCC phenotype (Trimborn et al., 2010). The knockout-
first allele mouse model with an insertion between exons
3--4 (Mcph1tm1a(EUCOMM)Wtsi) showed brain weight reduction
(∼15%); however there was no evidence of growth retardation
(Chen et al., 2013). Both of these Mcph1 models are hypomorphic
mutants with detectable residual wild-type transcript, and it
is thus difficult to interpret these phenotypes and compare
them to the other Mcph1 null mutants and human MCPH1
patients.
Mouse Models of Mcph1 Deficiency:
Non-Brain Phenotypes
A number of other phenotypes have been reported in the Mcph1
mutant mice (Table 2). Infertility has been observed in the
two null mutants (Liang et al., 2010; Gruber et al., 2011; Zhou
et al., 2013) and one of the hypomorphic mutants (Chen et al.,
2013). Phenotypes were observed in both spermatogenesis and
in the ovary (Liang et al., 2010). Germline phenotypes have
also been reported for mouse models of ASPM (Pulvers et al.,
2010; Fujimori et al., 2014). This raises the important question
of whether infertility, or testicular or ovarian atrophy, is seen
in human primary microcephaly. So far no cases have been
reported and the relationship between primary microcephaly and
infertility in humans remains an interesting question, as it may
provide clues to the mechanism of the gene, and also raises the
possibility that the function of MCPH1 in the germline may
have been the target of positive selection in the primate lineage
(Woods et al., 2006; Dobson-Stone et al., 2007; Timpson et al.,
2007).
In one of the Mcph1 hypomorphic mutants
(Mcph1Gt(RRO608)Byg), homozygous mice exhibited a shortened
lifespan, specifically a significant difference in survival after
65 weeks of age (Trimborn et al., 2010). This observation of
decreased overall survival in Mcph1 homozygous mutants was
replicated in the Mcph1tm1.2Kali null mutant, which manifests
an increased cancer susceptibility (Liang et al., 2014). This
difference in survival was not reported in the other mutants
(Gruber et al., 2011; Chen et al., 2013; Zhou et al., 2013); however
as the difference becomes apparent when mice are older, a
shortened lifespan may have been overlooked. This raises
the question of whether patients with primary microcephaly
exhibit a shortened lifespan, independent of other comorbidities
that may be exacerbated by the associated mental retardation.
Epidemiological studies may be difficult due to the rarity of
MCPH. However, one post-mortem case report of a 77-year old
with primary microcephaly exists (McCreary et al., 1996) and
another study reports on MCPH patients ranging to their 70 s
(Darvish et al., 2010) indicating that the condition is compatible
with normal lifespan.
Another interesting phenotype of Mcph1 mutant mice
reported in two studies (Liang et al., 2010; Chen et al., 2013) is a
significantly reduced proportion of homozygous mice (10∼15%
vs. the expected normal 25% Mendelian ratio) born from
intercrossing of heterozygous Mcph1 mutant mice. This indicates
the possibility of an embryonic lethal phenotype of varying
penetrance caused by homozygous mutations in Mcph1.
MCPH1 and Neurogenesis
The vastly complex cerebral cortex has its developmental
origin in the germinal zone, or ventricular zone (VZ), of the
dorsal telencephalon of the neural tube (Götz and Huttner,
2005). The VZ is composed of neuroepithelial cells, which
line along the ventricles of the embryonic brain vesicles and
spinal cord, and serve as the primary progenitor cells of all
neural cells of the central nervous system. Neuroepithelial cells
exhibit typical epithelial cell characteristics, such as apical-
basal polarity (Chenn et al., 1998), and its nuclei undergo a
unique movement in the apical-basal axis correlated with the
cell cycle, termed interkinetic nuclear migration (Sauer, 1935;
Taverna and Huttner, 2010; Kosodo, 2012), which gives the
tissue a pseudostratified histological appearance, and thus its
classification as a pseudostratified epithelium. Neuroepithelial
cells, or neural progenitor cells, initially proliferate to expand
the progenitor pool, and later commence differentiative divisions
into downstream progenitors and neurons (Paridaen and
Huttner, 2014), the process of neurogenesis.
In cortical development, the lateral dimension of the laminar
structure is largely dictated by the expansion of neural progenitor
cells or proliferative units, and the radial dimension is a
result of the extent of neurogenesis subsequent to progenitor
proliferation within an ontogenetic column or radial-unit (Rakic,
1988, 1995, 2009). This framework allows the dissection of
cortical phenotypes, where a reduction in the lateral dimension
is likely a deficit in the initial progenitor pool and its
subsequent proliferative expansion, and a reduction in the
radial dimension may be caused by a reduced capacity for
neurogenesis, shortening of the neurogenic interval, or neuronal
loss. Conceptually, an analysis distinguishing the radial and
lateral dimensions is useful in phenotypic dissection of mutant
mice to further clarify their respective impact on the final
neurogenic outcome.
Mcph1 inactivation has an impact on both lateral and radial
dimensions (Gruber et al., 2011; Zhou et al., 2013). These
characteristics have been related to a loss of progenitors and
to a specific decrease in upper layer neuron output, possibly
due to premature progenitor exhaustion. They appear to result
from the deficiency of two distinct Mcph1 functions: the control
of the centrosome cycle through the Chk1-Cdc25 pathway,
and DNA damage repair. The relative contribution of each
deficiency in this progenitor loss has not been addressed and
will require further studies. Likewise, it will be interesting to
address whether the aforementioned participation of Mcph1
in chromatin conformation during DNA repair could also
be important for chromatin conformation with regards to
progenitor fate determination during neurogenesis. In line
with this notion, competitive interactions between BAF170 and
BAF155 with Pax6 have been shown to play an important role
in the choice between cell cycle maintenance vs. differentiation
(Tuoc et al., 2013). Interestingly, mutations of several BAF
genes, including BAF170 and BAF155, have been reported to be
involved in brain disorders (Ronan et al., 2013), and it will be
interesting to further explore how interactions between BAF and
MCPH1 proteins impact brain size and function.
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The full interpretation of the defects reported for Mcph1
mutant mice is hampered by the lack of detailed information on
the pattern of Mcph1 expression during cortical development,
such as the temporal dynamics of gene activation, the cell types
expressing the gene and the sub-cellular localization of the
Mcph1 protein. It remains thus difficult to establish a direct link
between the described phenotypes and gene function. Moreover,
gaining insight into the spatio-temporal mode of MCPH1
expression in mouse and human will also allow the delineation
of how the function of the gene may have diverged between
both species. In particular, it will be interesting to determine
if MCPH1, along with other MCPH genes, are expressed in
the OSVZ (outer subventricular zone) progenitors (Smart et al.,
2002), and eventually how the MCPH genes may impact the
proliferation rate and division mode of these progenitors, which
are considered to be involved in the expansion of the surface area
of the neocortex (Lui et al., 2011; Betizeau et al., 2013; Sun and
Hevner, 2014).
MCPH1 and Brain Evolution
Ever since the identification of MCPH genes, there has been
intense interest in their possible roles in the evolution of
brain size (Evans et al., 2004; Wang and Su, 2004; Ponting
and Jackson, 2005; Woods et al., 2005). Microcepaly (primary
microcephaly, or microcephaly vera) has long been the subject of
evolutionary interest, and is commonly described in the literature
as an atavistic (or ‘‘throwback’’) condition, a reversion to an
ancestral form (Mochida and Walsh, 2001; Gilbert et al., 2005;
Ponting and Jackson, 2005; Vallender et al., 2008). In fact,
microcephaly was already proposed in the mid-19th centrury
by Carl Vogt to be the reappearance of an ancestral primate
(Komai et al., 1955; Richardson, 2011). Much of the intrigue
and fascination of research into MCPH genes has been fueled by
the remarkable phenotype of primary microcephay: a significant
and specific reduction in brain size with the absence of other
neurological and non-neurological abnormalities (Woods et al.,
2005). However, as little is known about the actual disturbance in
cortical structure and cytoarchitecture in MCPH, and since the
neuroanatomy of ancestral primates and hominids may forever
remain in the realm of speculation and extrapolation from
the comparison of extant species (Holloway, 1968; Rilling and
Insel, 1999; Falk et al., 2000), parallels between the pathological
condition of microcephaly, and the evolutionary change in
primate brain size must be made with caution. Moreover,
MCPH cannot be described as ‘‘atavistic’’ in genetic terms, as
all mutations identifyed so far, whether they result in loss-of-
function or the truncated MCPH1 protein has a toxic effect, are
mutations predicted to cause gene dysfunction, not a reversal
to an ancestral sequence (Gilbert et al., 2005). However, the
MCPH phenotype does provide insight into a cell biological
mechanism of brain size regulation, which may indeed have been
involved in primate brain evolution (Bond and Woods, 2006;
Fish et al., 2008; Thornton and Woods, 2009; Sun and Hevner,
2014).
Intriguinly, Mcph1 loss of function in mice primarily affects
the number of upper-layer neurons (Zhou et al., 2013), which are
very important for intra-cortical connections and are involved
in higher cognitive functions. The output of these neurons
has increased during evolution correlating with increasing
complexity of cognitive functions, as observed in humans and
primates (DeFelipe et al., 2002; Molnar et al., 2006; Fame et al.,
2011). The participation of MCPH genes in the development
of upper-layer neurons (Lizarraga et al., 2010; Yang et al.,
2012; Zhou et al., 2013) may thus represent a major clue for
understanding the evolution of brain size and function.
Regarding studies on the evolution of MCPH genes, interest
has generally centered on (i) the possibility of genetic variations
in these genes being directly involved in brain size regulation
during primate and human evolution; or (ii) through the analysis
of the function of these genes a molecular mechanism or pathway
regulating brain size may be identified.
MCPH1: Positive Selection and Polymorphisms
With regards to variations in MCPH1, studies have focussed
on either the analysis of positive (or Darwinian) selection of
MCPH1 in extant primate species, or through the analysis
of polymophisms in human populations. Positive selection
in the context of protein evolution can be studied by the
analysis of the ratio of non-synonymous (Ka) to synonymous
(Ks) changes in DNA sequence (Yang and Bielawski, 2000;
Hurst, 2002), and has commonly been used in investigating
the link between brain development and evolution (Dorus
et al., 2004; Gilbert et al., 2005). Briefly, since synonymous
mutations in codons do not change amino acid sequence
and therefore do not alter the biochemical properties of the
protein, they are assumed to be selectively neutral and reflect
the neutral mutation rate. Non-synonymous mutations on the
other hand, alters the amino acid sequence which may in turn
alter protein function, which more commonly would lead to
gene dysfunction and an evolutionary disadvantage, and rarely
may confer a gain-of-function or an evolutionary advantage
(Woods et al., 2005). Therefore a non-synonymous/synonymous
substitution ratio (Ka/Ks or dN/dS) of >1 can be interpreted
as evidence for positive selection. Utilizing these methods,
MCPH1 was found to exhibit positive selection in the
primate lineage, specifically from the common ancestor of
great apes and humans (Evans et al., 2004; Wang and Su,
2004). Another study which investigated four microcephaly
genes across 21 species of anthropoid primates identified
positive selection correlating with neonatal and adult brain
size for ASPM and CDK5RAP2, but interestingly not for
MCPH1 and CENPJ (Montgomery et al., 2011). Positive
selection of MCPH1 was also identified in cetaceans, which
was however also not associated with variations in brain size
(McGowen et al., 2011). Examination of positive selection
of microcephaly genes across 33 eutherian mammal species
revealed signs of positive selection of MCPH1 across non-
primate mammals, however MCPH1 did not correlate with
neonatal brain size (Montgomery and Mundy, 2014). How
MCPH1 may be involved in brain size regulation more broadly
across vertebrates and whether variations show any correlations
between gyrencephalic vs. non-gyrencephalic species remains an
interesting question.
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A large number of non-pathogenetic mutations or
polymorphisms in MCPH1 are known, particularly in exon
8 and 13 (Scala et al., 2010). One of which, c.940G>C
(p.Asp314His, non-conservative missense from negatively
to positively charged, exon 8; rs930557), has received much
attention. This polymorphism which is diagnostic for a
haplotype with the derived C allele, designated as haplogroup
D, has a relatively young coalescence age (i.e., time to single
ancestral copy) of 37,000 years, however with a high population
frequency worldwide, indicating strong positive selection among
anatomically modern humans (Evans et al., 2005). Further
analysis on the origin of haplogroup D indicated its divergence
1.1 million years ago from the human lineage and subsequent
introgression of this derived allele into human populations
37,000 years ago, possibly due to interbreeding between
humans and an archaic homo species, which was speculated as
Neanderthals (Evans et al., 2006). Although Neanderthals were
suggested as the possible archaic homo (Hawks et al., 2008),
subsequent sequencing of MCPH1 of Neanderthals revealed the
non-D (ancenstral) haplotype (Green et al., 2010; Lari et al.,
2010).
A large number of studies have attempted at identifying
associations between MCPH1 haplogroup D and a variety of
brain-related phenotypes. In short, no associations have been
identified with regards to HC, brain size by MRI, IQ or mental
retardation (Woods et al., 2006; Dobson-Stone et al., 2007;
Mekel-Bobrov et al., 2007; Rushton et al., 2007; Timpson et al.,
2007; Bates et al., 2008; Maghirang-Rodriguez et al., 2009). One
study identified an association with the population freqency
of haplogroup D and linguistic tone (Dediu and Ladd, 2007),
although a later study showed that the derived allele is not
associated with lexical tone perception (Wong et al., 2012).
The derived allele of another MCPH1 polymorphism,
c.2282T>C (p.Val761Ala, conservative missense from non-polar
to non-polar, exon 13; rs1057090), was associated with an
increase in cranial volume in Chinese males, but not females
(Wang et al., 2008). Non-exonic common variants in MCPH1
have been associated with brain size and cortical surface
area in females (Rimol et al., 2010), and another study has
investigated MCPH genes and their association with sexual
dimorphism in brain size in primates (Montgomery and Mundy,
2013). Mechanistically, how MCPH1 may contribute to sexually-
dimorphic brain phenotypes remains unclear.
Key questions remain as to whether MCPH1 did play a
role in the evolution of brain size in the primate lineage, and
whether common variants of MCPH1 in human populations
today are associated with any structural or functional brain
phenotype. In light of the phenotypic data from mouse models
(Liang et al., 2010; Trimborn et al., 2010; Gruber et al.,
2011; Chen et al., 2013; Zhou et al., 2013) which implicate
MCPH1 in a number of other non-nervous systems, notably
the germline, positive selection in primates and humans may
not be due to adaptive changes in brain size or function
(Woods et al., 2006; Dobson-Stone et al., 2007; Timpson et al.,
2007). In this context it is interesting to note that a large
scale study of human and chimpanzee orthologs for evidence
of positive selection revealed a large number of genes involved
in tumor suppression, apoptosis, and spermatogenesis (Nielsen
et al., 2005); functions where MCPH1 may play a major role.
Interestingly, two MCPH1 polymorphisms have been associated
with breast cancer risk (Jo et al., 2013), which further stresses
the need of examining non-nervous system phenotypes in the
context of MCPH1 evolution and also in primary microcephaly
patients.
MCPH1 Evolution: From a Cell Biological
Perspective
Cortical development in rodents and primates share many
features, however there are a number of important differences
relevant for brain size evolution. A key difference and one
that is of relevance to MCPH1, is the mechanisms which
regulate the production of progenitors in the OSVZ, the germinal
compartment which has enlarged strikingly in primates and
humans and is considered as the seat of the evolutionary
expansion of neocortical surface area (Smart et al., 2002;
Lui et al., 2011; Sun and Hevner, 2014). The analysis and
comparison of these differences in progenitor cell types and
lineage relationships, germinal layer cytoarchitecture, and cell
biological mechanisms will help in constructing a model of
mammalian brain evolution from a developmental and cell
biological perspective (Fish et al., 2008; Rakic, 2009; Fietz
and Huttner, 2011; Lui et al., 2011; Sun and Hevner, 2014).
Another clue recently emerged is the importance of DNA
repair pathways, revealed by a preferential effect of mutations
of genes implicated in such pathways, including MCPH1, on
neural progenitors (Gilmore and Walsh, 2013). This suggests the
existence of a specific cross-talk between DNA repair pathways
and primary cell cycle functions in these progenitors, which
might have become more critical during evolution. Integrating
these molecular findings with genetics and evolutionary biology
will be a powerful approach in investigating brain size evolution
(Enard, 2014).
With regards to MCPH1, some studies have taken this
approach in investigating its function in brain size evolution.
One study identified an E2F1 binding motif in the MCPH1
promoter region, which is specific to primates and absent
in mice and other vetebrates (Shi and Su, 2012). E2F1 is a
transcription factor regulating genes involved in cell cycle and
apoptosis (Ginsberg, 2002), and interestingly MCPH1 is involved
in transcriptional regulation of several DNA repair, checkpoint
and apoptosis genes, via interaction with E2F1 (Yang et al.,
2008). Another study performed a cell line assay comparing
human and rhesus macaque MCPH1 protein and its affects on
down-stream gene expression, and found that human-specific
amino acid changes in MCPH1 led to differences in expression
of three downstream genes involved in cell cycle regulation and
apoptosis (Shi et al., 2013). These studies go beyond correlating
genetic changes with brain size, and attempt to experimentally
test the hypothesis that MCPH1 is an important gene in
brain size evolution. Futher approaches may be to generate
humanized and primatized mice expressing human and other
primate MCPH1 (Pulvers et al., 2010), or the use of cerebral
organoids (Lancaster et al., 2013), an in vitro model of human
cortical development, where microcephaly-causing mutations
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in humans and primate-specific variants in MCPH1 can be
investigated in detail in a system amenable to experimentation
(Enard, 2014). Gene expression profiling studies aimed at
identifying pathways dependent on MCPH1 in mouse and
human, as well as the characterization of molecular partners
for both the mouse and human proteins, will provide major
clues on the molecular mechanisms involving MCPH1 and
its role in the evolution of brain size. Much may be learnt
regarding the role of MCPH genes in brain size evolution,
from constructing developmental and cell biological tools for
analyzing evolutionary questions.
MCPH1 is well-positioned as a candidate gene for
understanding the mechanisms of brain size evolution, as it
is related not only to the other primary microcephaly genes
with regards to its phenotype, but also harbors the same BRCT
domains as BRCA1, which has also been shown to be important
for brain development (Pulvers and Huttner, 2009; Pao et al.,
2014) and shows positive selection in the primate linage (Huttley
et al., 2000; Lou et al., 2014).
Conclusions
Advances in medical genetics have greatly enhanced our
understanding of the origins of many brain and nervous
system development disorders; microcephaly in particular.
Nevertheless, the molecular and cellular processes underlying
such disorders remain poorly understood, and gaining insight
into the pathological mechanisms has remained as a major
challenge in developmental neurobiology. In this respect,
microcephaly of genetic etiology represents a valuable context for
the study of the mechanisms that control the final neurogenic
output, and by extension to animal models, to assess how
these mechanisms have been adjusted and modulated during
evolution along with the remarkable expansion of brain size.
So far, interests have focused mainly on aspects related to cell
division and proliferation; however the pathological mechanisms
associated with microcephaly may prove to be more complex
and multifactorial. In line with this notion, MCPH1 appears
to assume multifaceted functions, including but not limited to:
brain development (Jackson et al., 1998, 2002), DNA damage
repair (Xu et al., 2004; Lin et al., 2005; Peng et al., 2009),
chromosome condensation (Neitzel et al., 2002; Trimborn
et al., 2004; Yamashita et al., 2011), cancer (Chaplet et al.,
2006; Rai et al., 2006; Richardson et al., 2011), and germline
function (Liang et al., 2010), as reviewed here and elsewhere
(Venkatesh and Suresh, 2014). Further comparative expression
and functional studies in different species, including primates,
will prove to be highly informative in further delineating the
molecular and genetic networks controlled by MCPH1, and how
they may have been tuned or co-opted to participate in the
expansion of brain size. Such progress in the understanding of
fundamental developmental mechanisms of the brain is expected
to have a valuable impact not only in the understanding of
clinical conditions such as microcephaly, but also to answer
one of the most enduring questions in biology: the evolution of
brain size.
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